Hydrogen sulfide treatment induces angiogenesis after cerebral ischemia

Journal of Neuroscience Research

Volumn 92, Issue 11, 2014, Pages 1520-1528

  Jang, Hyunduk ^a,b   Oh, Mi Young ^a,b   Kim, Young Ju ^a,b   Choi, In Young ^a,b   Yang, Hye sung ^a,b   Ryu, Wi Sun ^a,b,c   Lee, Seung Hoon ^a,b   Yoon, Byung Woo ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Acute stroke; Angiogenesis; Animal models; Cell culture; Cerebrovascular disease

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOPOIETIN 1; HYDROGEN SULFIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; GLUCOSE; ONCOPROTEIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; ASTROCYTE; BRAIN ISCHEMIA; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUBE FORMATION ASSAY; WOUND HEALING ASSAY; ANALYSIS OF VARIANCE; ANIMAL; ANOXIA; BRAIN INFARCTION; CELL CULTURE; COMPLICATION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; NERVOUS SYSTEM DISEASES; TUNEL ASSAY;

ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; ANIMALS; ANOXIA; BRAIN INFARCTION; BRAIN ISCHEMIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GLUCOSE; HYDROGEN SULFIDE; IN SITU NICK-END LABELING; MALE; MAP KINASE SIGNALING SYSTEM; NEOVASCULARIZATION, PATHOLOGIC; NERVOUS SYSTEM DISEASES; ONCOGENE PROTEIN V-AKT; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84906318893     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23427     Document Type: Article

References (34)

1. Berra E, Milanini J, Richard DE, Le Gall M, Vinals F, Gothie E, Roux D, Pages G, Pouyssegur J. 2000. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 60:1171-1178.
2. Bland ST, Schallert T, Strong R, Aronowski J, Grotta JC, Feeney DM. 2000. Early exclusive use of the affected forelimb after moderate transient focal ischemia in rats: functional and anatomic outcome. Stroke 31:1144-1152.
3. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
4. Brunet A, Datta SR, Greenberg ME. 2001. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297-305.
5. Byrnes KR, Faden AI. 2007. Role of cell cycle proteins in CNS injury. Neurochem Res 32:1799-1807.
6. Calabro P, Samudio I, Willerson JT, Yeh ET. 2004. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110:3335-3340.
7. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ. 2009. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105:365-374.
8. Chen J, Cui X, Zacharek A, Jiang H, Roberts C, Zhang C, Lu M, Kapke A, Feldkamp CS, Chopp M. 2007. Niaspan increases angiogenesis and improves functional recovery after stroke. Ann Neurol 62:49-58.
9. Chen PL, Easton AS. 2011. Anti-angiogenic effects of resveratrol on cerebral angiogenesis. Curr Neurovasc Res 8:14-24.
10. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605.
11. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ. 2007. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 104:15560-15565.
12. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL. 2002. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105:1497-1502.
13. Jiang BH, Zheng JZ, Aoki M, Vogt PK. 2000. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A 97:1749-1753.
14. Kawasaki K, Smith RS Jr, Hsieh CM, Sun J, Chao J, Liao JK. 2003. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol 23:5726-5737.
15. King AL, Polhemus DJ, Bhushan S, Otsuka H, Kondo K, Nicholson CK, Bradley JM, Islam KN, Calvert JW, Tao YX, Dugas TR, Kelley EE, Elrod JW, Huang PL, Wang R, Lefer DJ. 2014. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proc Natl Acad Sci U S A 111:3182-3187.
16. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. 1994. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25:1794-1798.
17. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. 2001. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21:3995-4004.
18. Lee SH, Kim M, Yoon BW, Kim YJ, Ma SJ, Roh JK, Lee JS, Seo JS. 2001. Targeted hsp70.1 disruption increases infarction volume after focal cerebral ischemia in mice. Stroke 32:2905-2912.
19. Li Z, Wang Y, Xie Y, Yang Z, Zhang T. 2011. Protective effects of exogenous hydrogen sulfide on neurons of hippocampus in a rat model of brain ischemia. Neurochem Res 36:1840-1849.
20. Marti HH, Risau W. 1999. Angiogenesis in ischemic disease. Thromb Haemostas 82(Suppl 1):44-52.
21. Pratt PF, Medhora M, Harder DR. 2004. Mechanisms regulating cerebral blood flow as therapeutic targets. Curr Opin Invest Drugs 5:952-956.
22. Qu K, Chen CP, Halliwell B, Moore PK, Wong PT. 2006. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37:889-893.
23. Ren C, Du A, Li D, Sui J, Mayhan WG, Zhao H. 2010. Dynamic change of hydrogen sulfide during global cerebral ischemia-reperfusion and its effect in rats. Brain Res 1345:197-205.
24. Rikitake Y, Hirata K, Kawashima S, Ozaki M, Takahashi T, Ogawa W, Inoue N, Yokoyama M. 2002. Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arterioscler Thromb Vasc Biol 22:108-114.
25. Saito M, Hamasaki M, Shibuya M. 2003. Induction of tube formation by angiopoietin-1 in endothelial cell/fibroblast co-culture is dependent on endogenous VEGF. Cancer Sci 94:782-790.
26. Semenza GL. 2003. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732.
27. Shiojima I, Walsh K. 2002. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90:1243-1250.
28. Silvestre JS, Tamarat R, Ebrahimian TG, Le-Roux A, Clergue M, Emmanuel F, Duriez M, Schwartz B, Branellec D, Levy BI. 2003. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ Res 93:114-123.
29. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. 2003. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111:1843-1851.
30. Szabo G, Veres G, Radovits T, Gero D, Modis K, Miesel-Groschel C, Horkay F, Karck M, Szabo C. 2011. Cardioprotective effects of hydrogen sulfide. Nitric Oxide 25:201-210.
31. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, Cheng JQ, Jove R, Yu H. 2005. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24:5552-5560.
32. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, Li Q, Lu M, Chopp M. 2002. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 117:207-214.
33. Zhang Y, Granholm AC, Huh K, Shan L, Diaz-Ruiz O, Malik N, Olson L, Hoffer BJ, Lupica CR, Hoffman AF, Backman CM. 2012. PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice. Brain 135:2736-2749.
34. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. 2000. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106:829-838.